Recently, the latest review authored by Academician Zhao Yupei’s team from PUMCH was published in “Signal Transduction and Targeted Therapy” (IF: 38.104), which comprehensively covered the mechanisms of how metabolic dysfunctions in obesity and diabetes mellit...

Castleman disease (CD) is a rare disorder of the hematological system, included in China’s first catalog of rare diseases. Professor Li Jian’s team at PUMCH has long been dedicated to clinical research of this disease. The team took the lead in establishing Ch...

On March 25, 2023, the 35th Science and Health Roundtable was held at PUMCH. Academician Zhao Zhongxian, winner of the National Highest Science and Technology Award, Academician Jiang Jiandong, Director of the Institute of Materia Medica, Chinese Academy of Me...

A new study by Professor Li Taisheng’s team at the Department of Infectious Diseases, PUMCH has shown that (5R)-5-hydroxytriptolide, the national Class I new drug developed by modifying the traditional Chinese medicine Tripterygium wilfordii Hook F (TwHF), is ...